Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.380 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
32 33 34 35 36 37 38 39 Next >
News headline image
Why This Cassava Sciences Analyst Is Dropping Coverage ↗
The selling in Cassava Sciences, Inc. (NASDAQ:SAVA) stock ... 
Via Benzinga
News headline image
SHAREHOLDER ALERT: RKT DIDI SAVA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / August 30, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Initial Public Offering Lawsuit
News headline image
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline – SAVA
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
3 Reasons Cassava Sciences Stock Isn't Worth the Risk ↗
There is a lot of smoke. Is there fire? 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Valneva (NASDAQ:VALN) stock rose 17.45% to $45.22 during Monday's pre-market session. The market value of their outstanding shares is at $2.2 billion.... 
Via Benzinga
News headline image
Cassava Sciences Is on the Ropes, so Watch for a Dip-Buy Opportunity ↗
Amid a regulatory tug-of-war over a proposed Alzheimer's disease treatment, SAVA stock has become a speculator's playground. 
Via InvestorPlace
News headline image
CLASS ACTION UPDATE for LOTZ, CRMD and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / August 30, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
News headline image
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week ↗
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and... 
Via Talk Markets
News headline image
60 Biggest Movers From Friday ↗
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition... 
Via Benzinga
News headline image
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRAC, BLCT and SAVA
NEW YORK, NY / ACCESSWIRE / August 29, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Topics Lawsuit
News headline image
SHAREHOLDER ALERT: CRMD ATIP SAVA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / August 29, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Lawsuit
News headline image
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week ↗
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (... 
Via Benzinga
News headline image
CASSAVA UPDATE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
SAVA ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Cassava Sciences, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
CASSAVA SHAREHOLDER NOTICE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
CLASS ACTION UPDATE for REKR, BZ and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / August 27, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, PHG and SAVA
NEW YORK, NY / ACCESSWIRE / August 27, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Topics Lawsuit
News headline image
The Law Offices of Frank R. Cruz Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Mid-Afternoon Market Update: Crude Oil Rises 2%; Navios Maritime Acquisition Shares Climb On Merger News ↗
Toward the end of trading Friday, the Dow traded up 0.63% to 35,436.38 while the NASDAQ rose 1.23% to 15,130.14. The S&P also rose, gaining 0.88% to 4,509.16. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Major Benchmarks Gain Amid Economic Stimulus Commentary ↗
Investors are unpacking comments by Federal Reserve Chairman Jerome Powell. 
Via Talk Markets
Topics Economy
News headline image
Most Active Equity Options For Midday - Friday, Aug. 27 ↗
Top Tickers: AAPL, TSLA, AMD, NVDA, PLTR, AMC, BABA, PTON, BBIG, F, SPRT, MSFT, AMZN, FB, PFE, MRNA, BAC, NFLX, SAVA, MARA. 
Via Talk Markets
News headline image
Mid-Day Market Update: Dow Jumps Over 200 Points; Bill.com Shares Spike Higher ↗
Midway through trading Friday, the Dow traded up 0.69% to 35,457.78 while the NASDAQ rose 1.03% to 15,099.70. The S&P also rose, gaining 0.79% to 4,505.38. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
35 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 87% to $36.83 on abnormally high volume amid continued volatility. The stock has recently been mentioned as a potential... 
Via Benzinga
News headline image
Why the Cassava Sciences Bears Are Wrong ↗
The stock's been a wild ride for investors all year, and it's dropped about 40% in two days. What's going on, and why am I bullish? 
Via The Motley Fool
News headline image
Why Cassava Sciences Is Plunging Again Today ↗
More red flags are emerging for this troubled Alzheimer's biotech company. 
Via The Motley Fool
News headline image
Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations ↗
The lab that tested samples for Cassava's Alzheimer's study distanced itself from the biotech Friday, and SAVA stock plunged again. 
Via Investor's Business Daily
News headline image
Why Cassava Sciences Stock Investors Are Pulling Back ↗
The neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) hasnow lost half of its market capitalization as skeletons continue to tumble out of... 
Via Benzinga
News headline image
Which Biotech Stock Will Shock the Market in 2022? ↗
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022? 
Via The Motley Fool
< Previous 1 2
...
32 33 34 35 36 37 38 39 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.